Healthcare - Biotechnology - NASDAQ - US
$ 3.16
-15.1 %
$ 8.83 M
Market Cap
-0.8
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
24935.09%
EBIT
Estimate
--523.55%
Net Income
Estimate
691.38%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Vaccinex, Inc.
VCNX has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart VCNX
EBIT FORECAST
EBIT Forecast Chart VCNX
NET INCOME FORECAST
Net Income Chart VCNX